Connect with us

Cannabis

New data available on home care and mental health and addictions

Published

on

Reading Time: 4 minutes

 

Canadians now have more information about home and community care and mental health and addictions services in their province or territory. Today, the Canadian Institute for Health Information (CIHI) released 3 new indicators that show how Canada’s health systems are faring when it comes to how many Canadians

  • Are hospitalized because of harm caused by substance use
  • Seek frequent emergency room (ER) care for help with mental health and/or addictions
  • Have their hospital stay extended because the right home and community care services and supports are not ready

These indicators are the first 3 of 12 chosen by the federal, provincial and territorial health ministries, in consultation with Canadians, to measure access to mental health and addictions services and to home and community care.

“The development of these new indicators has been a major collaborative effort between the ministries, system experts, CIHI and people with lived experiences. While it will take time for improvement efforts to be reflected in the indicators, health system decision-makers now have more tools to start discussions about how to target services and measure improvements, as well as to make better evidence-based decisions about how to deliver care to Canadians. CIHI is proud to be part of this effort to increase our knowledge of the mental health and addictions and home care sectors, which are very important services for all of us.”

—   David O’Toole, President and CEO, Canadian Institute for Health Information

“The Government of Canada has now signed bilateral agreements with all provinces and territories, setting out the details of ‎how federal investments to improve access to home and community care and mental health and addictions services will be spent. I believe it is important that Canadians see the results for investments in these priority areas. The indicators released today will serve as an initial set of invaluable metrics to help track improvements to access needed health services for all Canadians.”

—   Ginette Petitpas Taylor, Minister of Health

“All governments and system providers recognize the need to make home and community care and mental health services more accessible. The hospital-based indicators released today are a starting point to launch the discussion about access based on existing available data for these sectors. CIHI is committed to working with our partners to collect and report on additional data in community-based sectors.”

—   Kathleen Morris, Vice President, Research and Analysis, Canadian Institute for Health Information

This first year of results provides a baseline against which to track improvements over time. It will take time for new investments and renewed focus to have an impact on indicator results.

The indicator results are available in the Your Health System: In Brief web tool at the provincial and territorial levels. A companion report is available to provide context and assist with interpretation.

Indicator highlights

Hospital Stays for Harm Caused by Substance Use

This indicator measures how many hospital stays are a direct result of substance use, including alcohol, cannabis, cocaine and other drugs.

The first-year results, based on 2017–2018 data, show the following:

  • Every day, more than 400 Canadians were hospitalized due to harm caused by alcohol or drugs, more than the number of hospital stays for heart attacks and strokes combined.
  • 2 out of 3 of these hospital stays were for men.
  • About 40% of Canadians who had hospital stays caused by substance use also had a mental health condition such as anxiety, depression or schizophrenia.
  • Alcohol consumption was the top cause of hospitalization for harm attributed to substance use across all jurisdictions, accounting for more than half of these hospital stays. After alcohol, cannabis and opioids were among the top drugs leading to hospital stays for substance use in adults. For children and youth, these hospital stays were more likely to be caused by cannabis than by alcohol or other substances.

This hospital-based indicator represents only some of the services needed by individuals with substance use and addictions issues. Substance use and addictions are complex, and this indicator reflects long-term outcomes of public health efforts, and community and social services. It also reflects the needs of different populations, which are impacted by factors such as income, education, social networks, housing, and personal and/or intergenerational trauma.

Frequent Emergency Room Visits for Help With Mental Health and/or Addictions

This indicator measures how many Canadians visited the ER 4 or more times in 1 year. Many factors can influence these indicator results, including the needs and characteristics of the population as well as community-based health and social programs.

In jurisdictions where ER data is available, the analysis found the following:

  • 1 in 10 Canadians who visited an ER for help with mental health and/or addictions did so at least 4 times in 1 year.
  • Half of these frequent ER visits were related to patients who were treated for both a mental health condition and an addiction.
  • Half of frequent ER users who visited for help with mental health and/or addictions were younger than 35.

Due to partial data coverage in some provinces and territories, data for this indicator is not yet comparable.

Hospital Stay Extended Until Home Care Services or Supports Ready

Home care is a vital service for many Canadians who need assistance but do not require hospital care. This indicator measures the number of days patients remain in hospital while waiting for home care services or supports to be ready.

According to the data,

  • More than 90% of hospital patients had access to home care services as soon as they were ready to be discharged from hospital. But 1 in 12 had their stay extended because the services or supports were not ready.
    • This is the equivalent of 3 large hospitals filled each day with people who did not need hospital care.
  • A typical extended stay was 7 days or less, but 1 in 10 extended stays was 39 days or more.
  • Patients with extended hospital stays tend to be older women.

New results for health system performance indicators

In addition to the release of the 3 new indicators measuring access to mental health and addictions and home care services, CIHI has also updated the results for 31 existing health system performance indicators and contextual measures in the Your Health System web tool and Health Indicators e-publication.

 

SOURCE Canadian Institute for Health Information

Cannabis

Sunniva Announces Closing Of Third Tranche Of Short Term Bridge Financing For Proceeds Of Cad $325,000

Published

on

Reading Time: 2 minutes

 

Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, is pleased to announce that it has closed the third tranche of the Company’s non-brokered private placement (the “Offering“), previously announced on August 1, 2019 of CAD $325,000 for a total of 325,000 units of the Company (“Units“). In aggregate the total gross proceeds raised by the Offering was CAD $7.57 million and 7.57 million Units issued. Each Unit consists of a principal amount of unsecured promissory notes of the Company (“Promissory Notes“) and common share purchase warrants of the Company (“Warrants“).

As previously disclosed, proceeds of the Offering will be used to provide short term working capital for operations in California, capital costs at the Sunniva California Campus and general corporate purposes.

The Units issued under the Offering have the following terms:

Promissory Notes  

     Maturity: 

6 months from the closing date.

     Interest Rate:

10% (annual rate).

Warrants 

     Number of Warrants:   

0.40 Warrants per Unit (each Warrant entitles the holder to acquire one common

share of the Company at the Warrant Exercise Price).

     Warrant Exercise Price:  

CAD $2.50 per Warrant.

     Warrant Term:         

24 months from closing.

A finder’s fee of 5% payable in cash will be paid to certain investment advisors for introducing certain purchasers of Units to the Company.

The Promissory Notes and Warrants have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Promissory Notes or Warrants in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

For more information please visit: www.sunniva.com.

To be added to the Sunniva email distribution list please register at www.sunniva.com/email-alerts.mailto:

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE Sunniva Inc.

Continue Reading

Cannabis

INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals

Published

on

Reading Time: 2 minutes

 

InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries (NYSE: and TASE: TEVA).

Under terms of the agreement, S.L.E. will distribute Canndoc’s GMP products to pharma clients, including hospitals, health maintenance organizations (HMOs) and all pharmacies in Israel, including pharmacy chains. In the future, as regulatory approvals allow, S.L.E. will provide logistics capability for exporting Canndoc’s products to countries that support regulations for the sale and distribution of cannabis products for medical use.

S.L.E. is one of Israel’s leading companies for providing health logistics services and distributes products from dozens of local and international companies. S.L.E. is licensed by the Israeli Ministry of Health, and also holds a GDP distribution license.

“Our agreement with S.L.E., Israel’s leading company in distributing medical products, creates a complete supporting platform for supplying Canndoc’s GMP products to any location in Israel and for countries with similar regulations,” said Canndoc’s Chairman Ehud BarakThrough its S.L.E. partnership, Canndoc has aligned itself with one of the most prominent pharmaceutical companies in the world, for the distribution of cannabis-based medical treatments to countries that recognize the value of these medicines for people in need.”

S.L.E. CEO Aviad Bossi adds, “The agreement brings together our well-established pharmaceutical distribution network with Canndoc’s high quality medical cannabis industry presence and market leadership. Beyond the operations in Israel, this agreement will provide Canndoc significant logistical capabilities that can support Canndoc’s exporting operations from Israel.”

The distribution agreement is set for a 3-year term and includes a mechanism for automatic extension periods of two years each.

Canndoc is one of the first licensed producers, with its GMP-approved medical cannabis Rx products being sold in pharmacies. The engagement in this distribution agreement will broaden Canndoc’s ability to distribute GMP products to its patients within the S.L.E. pharmacy network throughout Israel. In addition, S.L.E. will provide Canndoc significant logistical capabilities in the future supporting Canndoc’s ability to export its products to countries with consistent regulation for the sale and distribution of cannabis products for medical use.

 

SOURCE Canndoc

Continue Reading

Cannabis

Prairie Records Tops the Charts: Named Top Cannabis Retailer in Canada at Grow UP

Published

on

Reading Time: 1 minute

 

Westleaf Inc. (the “Company” or “Westleaf“) (TSX-V:WL) (OTCQB:WSLFF) is proud to announce its Prairie Records retail stores have been named top cannabis retailer in Canada at the GrowUP Conference & Expo. Singing a different tune in cannabis retail, the award win is a testament to how Prairie Records is offering Canadian’s a truly unprecedented purchasing experience.

“It is extremely gratifying to have Prairie Records be recognized at one of the industry’s largest events and to be able to stand out amongst a field of very worthy retail competitors,” says Adam Coates, Chief Commercial Officer at Westleaf and Retail Brand Strategist for Prairie Records. “We set out to make waves in a sea of sameness by creating an immersive experience like no other in the marketplace, and we are pleased and honoured to receive this, the first Grow UP Conference retail award.”

Ten companies were nominated in the Grow UP retail category at this year’s event, the first for the industry. Among the nominees were independent stores and well-known national chains. Prairie Records was recognized based on delivering an unparalleled consumer purchasing experience and creating a welcoming brand for cannabis consumers.

Westleaf has four Prairie Records stores open, three in the Saskatoon region and one in Calgary, which is hosting its grand opening tomorrow, September 14. The concept combines the tactile and immersive feel of a vinyl record store with a cannabis purchasing experience. Information about the cannabis strains and strengths are presented on album covers and the customer is enveloped in a warm and welcoming retail experience. The staff are well versed on the product offering and provide educational opportunities for both the experienced cannabis connoisseur as well as the novice consumer.

 

SOURCE Westleaf Inc.

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania